arrow
Back
L

Luca Gianni

Fondazione Michelangelo

94H-index
595Paper Count
5.8WCitation Count
Published Papers 160
Publication Date
Primary results from EL1SSAR, a prospective phase IIIb study of first-line atezolizumab plus nab-paclitaxel therapy for patients with PD-L1-positive advanced triple-negative breast cancer
err2026-06-08
err0
errOAAI
errL. Gianni; S. Delaloge; E. Ciruelos; O. Trédan; C. Castañeda; M.H. Abreu; I. Paris; M. Colleoni; G. Scandurra; M. Kwiatkowski; N. Antone; V. Gregorc; P. Tagliaferri; S. Borštnar; I. Blancas; M. Raimondo; M. Alfie; C. Arce-Salinas; P.S. Madeira; Y.G. Lin
errShare
errSave
Tumor-specific major histocompatibility-II expression predicts pathological complete response to atezolizumab combined to chemotherapy in triple-negative breast cancer
err2025-09-29
err0
errOAAI
errJustin M. Balko; Luca Licata; Xiao Qian Wang; Matteo Dugo; Chiun-Sheng Huang; Daniel Egle; Begoña Bermejo; Claudio Zamagni; Marc Thill; Antonio Anton; Stefania Russo; Elena Sevillano; Eva Maria Ciruelos; Richard Greil; Vladimir Semiglazov; Marco Colleoni; Catherine M. Kelly; Gabriella Mariani; Lucia Del Mastro; Stefania Zambelli; Giulia Viale; Maurizio Callari; Giuseppe Viale; Lajos Pusztai; Luca Gianni; H. Raza Ali; Giampaolo Bianchini
errShare
errSave
The association of high body mass index with the safety and efficacy of sacituzumab govitecan in patients with metastatic triple-negative breast cancer from the ASCENT study
err2025-06-01
err0
errOAAI
errL. García-Estévez; A. Bardia; H.S. Rugo; L.A. Carey; V.C. Diéras; S. Loibl; M. Piccart; L. Gianni; K. Kalinsky; J. O’Shaughnessy; S.A. Hurvitz; E. Harting; T. Valdez; S. Phan; C. Lai; J. Cortés
errShare
errSave
Two decades of advances in clinical oncology - lessons learned and future directions
err2024-10-01
err1
PREAI
errBanerjee, Susana; Booth, Christopher M.; Bruera, Eduardo; Buechler, Markus W.; Drilon, Alexander; Fry, Terry J.; Ghobrial, Irene M.; Gianni, Luca; Jain, Rakesh K.; Kroemer, Guido; Llovet, Josep M.; Long, Georgina V.; Pantel, Klaus; Pritchard-Jones, Kathy; Scher, Howard I.; Tabernero, Josep; Weichselbaum, Ralph R.; Weller, Michael; Wu, Yi-Long
errShare
errSave
Summary of quality of life in the ASCENT phase 3 clinical trial for people with metastatic triple-negative breast cancer : A plain language summary
err2024-09-26
err0
errOAAI
errLoibl, Sibylle; Loirat, Delphine; Tolaney, Sara M.; Punie, Kevin; Dieras, Veronique; Carey, Lisa A.; Gianni, Luca; Shah, Anuj; Phan, See; Shi, Ling; Spears, Patricia A.; Piccart, Martine J.
errShare
errSave
Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer (vol 8, 98, 2022)
err2024-06-06
err0
errOAAI
errRugo, Hope S.; Tolaney, Sara M.; Loirat, Delphine; Punie, Kevin; Bardia, Aditya; Hurvitz, Sara A.; O'Shaughnessy, Joyce; Cortes, Javier; Dieras, Veronique; Carey, Lisa A.; Gianni, Luca; Piccart, Martine J.; Loibl, Sibylle; Goldenberg, David M.; Hong, Quan; Olivo, Martin; Itri, Loretta M.; Kalinsky, Kevin
errShare
errSave
Pathologic complete response (pCR) of neoadjuvant therapy with or without atezolizumab in HER2-positive, early high-risk and locally advanced breast cancer: APTneo Michelangelo randomized trial
err2024-05-02
err4
PREAI
errGianni, Luca; Munzone, Elisabetta; Mansutti, Mauro; Bianchini, Giampaolo; Izarzuzaga, Yann; Caremoli, Elena Rota; Dirix, Luc; Del Mastro, Lucia; Gonzalez-Santiago, Santiago; Schneeweiss, Andreas; Ponce, Jose; Huang, Chiun-Shen; Wimberger, Pauline; Altintas, Sevilay; Martin, Miguel; Antone, Nicoleta; Singer, Christian F.; De Giorgi, Ugo; Ortiz, Ana Godoy; Lueck, Hans-Joachim; Spezia, Riccardo; Fasolo, Angelica; Viale, Giuseppe; Valagussa, Pinuccia
errShare
errSave
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy
err2023-11-07
err5
errOAAI
errLicata, Luca; Barreca, Marco; Galbardi, Barbara; Dugo, Matteo; Viale, Giulia; Gyorffy, Balazs; Karn, Thomas; Pusztai, Lajos; Gianni, Luca; Callari, Maurizio; Bianchini, Giampaolo
errShare
errSave
Event-free survival (EFS) analysis of neoadjuvant taxane/ carboplatin with or without atezolizumab followed by an adjuvant anthracycline regimen in high-risk triple negative breast cancer (TNBC): NeoTRIP Michelangelo randomized study
err2023-10-01
err8
PREAI
errGianni, L.; Huang, C.; Egle, D.; Bermejo, B.; Zamagni, C.; Thill, M.; Torres, A. Anton; Bianchini, G.; Fernandez, E. Sevillano; Russo, S.; Ciruelos, E. M.; Greil, R.; Semiglazov, V.; Colleoni, M. A.; Kelly, C. M.; Mariani, G.; Del Mastro, L.; Spezia, R.; Ali, H.; Viale, G.
errShare
errSave
Pathological complete response after neoadjuvant chemotherapy plus pertuzumab and trastuzumab for HER2+early breast cancer: Real-world data from NeoPowER study
err2023-10-01
err0
errOAAI
errCanino, F.; Barbolini, M.; De Giorgi, U. F. F.; Gianni, L.; Maestri, A.; Moscetti, L.; Omarini, C.; Zamagni, C.; Costantini, R. Cuoghi; Tamburrano, F.; Antonelli, G.; Baglio, F.; Belluzzi, L.; Martinelli, G.; Natalizio, S.; Ponzoni, O.; Dominici, M.; Piacentini, F.
errShare
errSave
HER2 positive breast cancer
err2023-03-01
err0
PREAI
errGianni, Luca; Bianchini, Giampaolo
errShare
errSave
Health-related quality of life in the phase III ASCENT trial of sacituzumab govitecan versus standard chemotherapy in metastatic triple-negative breast cancer
err2023-01-01
err29
errOAAI
errLoibl, Sibylle; Loirat, Delphine; Tolaney, Sara M.; Punie, Kevin; Oliveira, Mafalda; Rugo, Hope S.; Bardia, Aditya; Hurvitz, Sara A.; Brufsky, Adam M.; Kalinsky, Kevin; Cortes, Javier; O'Shaughnessy, Joyce A.; Dieras, Veronique; Carey, Lisa A.; Gianni, Luca; Gharaibeh, Mahdi; Preger, Luciana; Phan, See; Chang, Lawrence; Shi, Ling; Piccart, Martine J.
errShare
errSave
Incidence and severity of anaphylaxis and hypersensitivity in trials of intravenous pertuzumab plus trastuzumab or the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection for HER2-positive breast cancer
err2023-01-01
err1
errOAAI
errSwain, Sandra M.; Tan, Antoinette R.; Gianni, Luca; Kuemmel, Sherko; Dang, Chau T.; Schneeweiss, Andreas; O'Shaughnessy, Joyce; Liu, Haiying; Aguila, Christian; Heeson, Sarah; Macharia, Harrison; Yang, Ke; Restuccia, Eleonora; Loibl, Sibylle
errShare
errSave
Overall survival in the OlympiA phase Ill trial of adjuvant olaparib in patients with germime pathogenic variants in BRCA1/2 and high-risk, early breast cancer
err2022-12-01
err198
errOAAI
errGeyer, C. E., Jr.; Garber, J. E.; Gelber, R. D.; Yothers, G.; Taboada, M.; Ross, L.; Rastogi, P.; Cui, K.; Arahmani, A.; Aktan, G.; Armstrong, A. C.; Arnedos, M.; Balmana, J.; Bergh, J.; Bliss, J.; Delaloge, S.; Domchek, S. M.; Eisen, A.; Elsafy, F.; Fein, L. E.; Fielding, A.; Ford, J. M.; Friedman, S.; Gelmon, K. A.; Gianni, L.; Gnant, M.; Hollingsworth, S. J.; Im, S-A; Jager, A.; Lakhani, S. R.; Janni, W.; Linderholm, B.; Liu, T-W; Loman, N.; Korde, L.; Loibl, S.; Lucas, P. C.; Marme, F.; de Duenas, E. Martinez; McConnell, R.; Phillips, K-A; Piccart, M.; Rossi, G.; Schmutzler, R.; Senkus, E.; Shao, Z.; Sharma, P.; Singer, C. F.; Spanic, T.; Stickeler, E.; Toi, M.; Traina, T. A.; Viale, G.; Zoppoli, G.; Park, Y. H.; Yerushalmi, R.; Yang, H.; Pang, D.; Jung, K. H.; Mailliez, A.; Fan, Z.; Tennevet, I; Zhang, J.; Nagy, T.; Sonke, G. S.; Sun, Q.; Parton, M.; Colleoni, M. A.; Schmidt, M.; Brufsky, A. M.; Razaq, W.; Kaufman, B.; Cameron, D.; Campbell, C.; Tutt, A. N. J.; Johannsson, O. Th
errShare
errSave
errShare
errSave
A randomized phase II trial of metronomic oral vinorelbine plus cyclophosphamide and capecitabine (VEX) vs weekly paclitaxel (P) as first- or second-line treatment in patients (pts) with ER+/HER2-metastatic breast cancer (MBC): The METEORA-II trial (IBCSG 54-16)
err2022-09-01
err2
errOAAI
errMunzone, E.; Regan, M. M.; Cinieri, S.; Montagna, E.; Orlando, L.; Shi, R.; Campadelli, E.; Gianni, L.; De Giorgi, U. F. F.; Bengala, C.; Generali, D.; Collova, E.; Puglisi, F.; Cretella, E.; Zamagni, C.; Chini, C.; Goldhirsch, A.; Colleoni, M. A.
errShare
errSave
Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer
err2022-08-29
err56
errOAAI
errRugo, Hope S.; Tolaney, Sara M.; Loirat, Delphine; Punie, Kevin; Bardia, Aditya; Hurvitz, Sara A.; O'Shaughnessy, Joyce; Cortes, Javier; Dieras, Veronique; Carey, Lisa A.; Gianni, Luca; Piccart, Martine J.; Loibl, Sibylle; Goldenberg, David M.; Hong, Quan; Olivo, Martin; Itri, Loretta M.; Kalinsky, Kevin
errShare
errSave
Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab
err2022-07-05
err15
errOAAI
errLigorio, Francesca; Di Cosimo, Serena; Verderio, Paolo; Ciniselli, Chiara Maura; Pizzamiglio, Sara; Castagnoli, Lorenzo; Dugo, Matteo; Galbardi, Barbara; Salgado, Roberto; Loi, Sherene; Michiels, Stefan; Triulzi, Tiziana; Tagliabue, Elda; El-Abed, Sarra; Izquierdo, Miguel; de Azambuja, Evandro; Nuciforo, Paolo; Huober, Jens; Moscetti, Luca; Janni, Wolfgang; Coccia-Portugal, Maria Antonia; Corsetto, Paola Antonia; Belfiore, Antonino; Lorenzini, Daniele; Daidone, Maria Grazia; Vingiani, Andrea; Gianni, Luca; Pupa, Serenella Maria; Bianchini, Giampaolo; Pruneri, Giancarlo; Vernieri, Claudio
errShare
errSave
Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis
err2022-06-09
err45
errOAAI
errCarey, Lisa A.; Loirat, Delphine; Punie, Kevin; Bardia, Aditya; Dieras, Veronique; Dalenc, Florence; Diamond, Jennifer R.; Fontaine, Christel; Wang, Grace; Rugo, Hope S.; Hurvitz, Sara A.; Kalinsky, Kevin; O'Shaughnessy, Joyce; Loibl, Sibylle; Gianni, Luca; Piccart, Martine; Zhu, Yanni; Delaney, Rosemary; Phan, See; Cortes, Javier
errShare
errSave
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study*
err2022-05-01
err163
errOAAI
errGianni, L.; Huang, C. S.; Egle, D.; Bermejo, B.; Zamagni, C.; Thill, M.; Anton, A.; Zambelli, S.; Bianchini, G.; Russo, S.; Ciruelos, E. M.; Greil, R.; Semiglazov, V; Colleoni, M.; Kelly, C.; Mariani, G.; Del Mastro, L.; Maffeis, I; Valagussa, P.; Viale, G.
errShare
errSave